14 studies found for:    jtt-705
Show Display Options
RSS Create an RSS feed from your search for:
jtt-705
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
Condition: Type II Hyperlipidemia
Interventions: Drug: JTT-705 600 mg and pravastatin 40 mg;   Drug: JTT-705 300 mg and pravastatin 40 mg;   Drug: Placebo and pravastatin 40 mg
2 Completed Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
Condition: Type II Hyperlipidaemia
Interventions: Drug: Placebo;   Drug: JTT-705 300mg;   Drug: JTT-705 600mg;   Drug: JTT-705 900mg
3 Completed Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Condition: Dyslipidemia
Interventions: Drug: JTT-705 600 mg and simvastatin 40 mg;   Drug: Placebo and simvastatin 40 mg
4 Completed Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Condition: Dyslipidemia
Interventions: Drug: JTT-705 600 mg and atorvastatin 20 mg;   Drug: Placebo and atorvastatin 20 mg
5 Completed A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: atorvastatin;   Drug: dalcetrapib
6 Completed A Study of Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease
Condition: Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Interventions: Other: Background care;   Drug: Placebo;   Drug: dalcetrapib
7 Completed A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: placebo
8 Terminated A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Condition: Cardiovascular Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
9 Completed A Study of the Metabolic Profile of Dalcetrapib in Healthy Volunteers
Condition: Healthy Volunteer
Intervention: Drug: dalcetrapib
10 Completed A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
11 Completed A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
12 Completed A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
13 Completed A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
14 Completed A Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart Disease
Condition: Coronary Heart Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib

Indicates status has not been verified in more than two years